ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Which Will Market the First Chinese-produced Trastuzumab Biosimilar: Sunshine Guojian or Henlius?
June 15, 2020HER2-positive breast cancer has a high degree of malignancy and fast progression. Trastuzumab is the standard first-line regimen for adjuvant, neoadjuvant and metastatic cancer treatment of HER2-positive breast cancer. -
Sunshine Guojian Selects Verseau's VSIG4-targeted Antibody as the Second Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration
December 15, 20203SBio Inc.'s subsidiary, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. and Verseau Therapeutics, Inc. announced the selection of a monoclonal antibody targeting VSIG4, as a licensed program under their partnership agreement focused on the ...
Pharma Sources Insight January 2025
